Welcome, Guest |
TOPIC:
Phase II/III STORM-C-1 trial results from EASL 2018 6 years 3 weeks ago #26267
Brief article outlining the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris medicalxpress.com/news/2018-04-hepatitis...ation-treatment.html | |
Time to create page: 0.060 seconds